Search for a trial | Research with human participants

2 results

A Phase 3, Multicentre, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn's Disease

Approved WMORecruitment stopped

This study has been transitioned to CTIS with ID 2022-502841-91-00 check the CTIS register for the current data. The main reason for this study is to help in answering the following research question: - Whether mirikizumab can help patients with…

A Phase 3, Multicenter, Open-Label Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Ulcerative Colitis (LUCENT 3)

Approved WMORecruiting

This study has been transitioned to CTIS with ID 2023-507657-15-00 check the CTIS register for the current data. Study AMAP is a single-arm, outpatient, open-label, Phase 3, multicenter, long-term extension study evaluating the efficacy and safety…